Please use this identifier to cite or link to this item:
Title: Biomechanical modelling of the pelvic system: improving the accuracy of the location of neoplasms in MRI-TRUS fusion prostate biopsy
Author: Qasim, Muhammad
Puigjaner, Dolors
Herrero, Joan
López, Josep M.
Olivé, Carme
Fortuny, Gerard
Garcia Bennett, Josep
Keywords: Càncer de pròstata
Prostate cancer
Issue Date: 28-Mar-2022
Publisher: Springer Science and Business Media LLC
Abstract: Background An accurate knowledge of the relocation of prostate neoplasms during biopsy is of great importance to reduce the number of false negative results. Prostate neoplasms are visible in magnetic resonance images (MRI) but it is difficult for the practitioner to locate them at the time of performing a transrectal ultrasound (TRUS) guided biopsy. In this study, we present a new methodology, based on simulation, that predicts both prostate deformation and lesion migration during the biopsy. Methods A three-dimensional (3-D) anatomy model of the pelvic region, based on medical images, is constructed. A finite element (FE) numerical simulation of the organs motion and deformation as a result of the pressure exerted by the TRUS probe is carried out using the Code-Aster open-source computer software. Initial positions of potential prostate lesions prior to biopsy are taken into consideration and the final location of each lesion is targeted in the FE simulation output. Results Our 3-D FE simulations show that the effect of the pressure exerted by the TRUS probe is twofold as the prostate experiences both a motion and a deformation of its original shape. We targeted the relocation of five small prostate lesions when the TRUS probe exerts a force of 30 N on the rectum inner wall. The distance travelled by these lesions ranged between 5.6 and 13.9 mm. Conclusions Our new methodology can help to predict the location of neoplasms during a prostate biopsy but further studies are needed to validate our results. Moreover, the new methodology is completely developed on open-source software, which means that its implementation would be affordable to all healthcare providers.
Note: Reproducció del document publicat a:
It is part of: BMC Cancer, 2022, vol. 22, num. 1
Related resource:
ISSN: 1471-2407
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
s12885-022-09432-4.pdf2.02 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons